Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 14/20 | 0.43 |
| ▸ | CTSS | P25774 | 4/20 | 0.43 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7435300 | 0.95 | TDP1 (0.42) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7438051 | 0.92 | CA1 (0.41) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7437472 | 0.84 | CTSK (0.44) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7438236 | 0.81 | CA1 (0.45) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7445788 | 0.81 | CA1 (0.45) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL7442619 | 0.81 | CTSK (0.51) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7443440 | 0.80 | CA1 (0.48) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL16492732 | 0.80 | CAPN1 (0.49) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7430737 | 0.80 | CA1 (0.40) | CTSKCTSSCAPN1CA1CA2 | |
| SCHEMBL7444118 | 0.78 | CA1 (0.47) | CTSKCTSSCA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187905-B1 | PEPTIDE COMPOUND WHICH INHIBITS VIRAL PROTEINASES; VIRICIDES FOR HEPATITIS C, HEPATITIS G, AND HUMAN GB VIRUSES | HOFFMANN-LA ROCHE INC. | 2001-02-13 | — | — | US | disclosed |